View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
ACPS|29 May 2018

Teaching and Training

Continuous training is a good clinical practice (GCP) mandate. ACPS provides customised services for teaching and training that help its trainees understand not just how to do things, but why we do things in a certain way. To this purpose, the company has created a series of training modules on clinical pharmacokinetics, bioavailability and bioequivalence, pharmacovigilance for clinical trials, GCP, and good documentation practice (GDP) compliant trial master file (TMF) management.

The increasing complexity of the clinical development of novel drug products demands high-level qualification and expertise of all parties involved and at all levels of the management of clinical plans and the planning, conduct and reporting of clinical trials.

Irrespective of professional background training, most of us learn the job by just doing it, which works if well guided and supported by expert training.

Continuous training is a good clinical practice (GCP) mandate. In consequence, many resources have become available that provide excellent training opportunities. However, most of this training is targeted on how to do things, for example on formal topics.

ACPS likes to take its trainees one important step further: to understand why companies do things in a certain way. To this purpose, ACPS has created a series of training modules, including on topics such as clinical pharmacokinetics, bioavailability and bioequivalence, pharmacovigilance for clinical trials, GCP, good documentation practice for trial management file (TMF) management.

The firm provides such training at various levels and for various audiences.

In addition, the ACPS-Library holds several writings that address the many challenges of the pharmaceutical field and how best to meet them.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena